Home Cannabis FDA warns against misleading cannabis claims

FDA warns against misleading cannabis claims

through Ties Inc.

2022-05-06-FDA warns against misleading cannabis claims

The US Food and Drug Administration (FDA) has warned companies selling CBD and cannabis products, including delta-8 THC, against making unsupported claims about the products' health benefits.

The FDA said that while very little research has been done on delta-8 THC, a compound found in the cannabis sativa plant, online retailers and cafes claim that products containing the compound reduce anxiety or aid sleep. Delta-8 is derived from a similar part of the marijuana plant as CBD.

False Claims About Cannabis Benefits

The FDA said several people had been hospitalized after taking delta-8 and sent warning letters to five companies — ATLRx, BioMD Plus, Delta 8 Hemp, Kingdom Harvest and M Six Labs — for allegedly making false claims about its benefits.

“The FDA is deeply concerned about the growing popularity of delta-8 THC products sold online and in stores across the country,” said Janet Woodcock, FDA Deputy Commissioner. “It is extremely disturbing that some food items are packaged and labeled in ways that may appeal to children.”

The FDA's crackdown on delta-8 comes at a time when marijuana laws, which are still federally banned, are in flux. There is new impetus in Congress, from lawmakers in both major parties, to allow cannabis companies to use banking services, which would be an important step toward establishing their legitimacy in the US.

cash-only cannabis sector

The federal ban on cannabis forces cannabis dispensaries to trade in cash, making them a target for robberies. “This is currently a cash-only business. It's dangerous for the workers," Murray, a member of the Senate conference committee leading negotiations over the final draft of the bill, told the Hill. “It is dangerous for customers and staff and can be solved.”

Groups, including the American Bankers Association, are lobbying lawmakers to introduce a stand-alone bill that would allow banks to provide services to cannabis providers. They claim it will help reduce crime and increase tax revenues. Steve Daines, a Republican senator, said he is confident such a bill would get the required votes from both the GOP and Democratic lawmakers.

Last month, a bill decriminalizing marijuana at the federal level was passed by the US House of Representatives. However, it has yet to be voted in the Senate, and Joe Biden has yet to support the idea, despite promising to support the decriminalization of cannabis users during his presidential campaign.

Source: theguardian.com (EN)

Related Articles